Sensei Biotherapeutics Statistics
Total Valuation
SNSE has a market cap or net worth of $24.64 million. The enterprise value is -$34.91 million.
| Market Cap | 24.64M |
| Enterprise Value | -34.91M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, before market open.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SNSE has 25.07 million shares outstanding. The number of shares has decreased by -8.96% in one year.
| Shares Outstanding | 25.07M |
| Shares Change (YoY) | -8.96% |
| Shares Change (QoQ) | -2.08% |
| Owned by Insiders (%) | 34.65% |
| Owned by Institutions (%) | 10.55% |
| Float | 16.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.38 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.92, with a Debt / Equity ratio of 0.10.
| Current Ratio | 11.92 |
| Quick Ratio | n/a |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -235.81 |
Financial Efficiency
Return on equity (ROE) is -44.00% and return on invested capital (ROIC) is -52.13%.
| Return on Equity (ROE) | -44.00% |
| Return on Assets (ROA) | -38.60% |
| Return on Capital (ROIC) | -52.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.22M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.29% in the last 52 weeks. The beta is 0.16, so SNSE's price volatility has been lower than the market average.
| Beta (1Y) | 0.16 |
| 52-Week Price Change | -39.29% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 0.88 |
| Relative Strength Index (RSI) | 48.50 |
| Average Volume (30 Days) | 69,819 |
Short Selling Information
The latest short interest is 156,203, so 0.62% of the outstanding shares have been sold short.
| Short Interest | 156,203 |
| Short Previous Month | 145,856 |
| Short % of Shares Out | 0.62% |
| Short % of Float | 0.95% |
| Short Ratio (days to cover) | 1.80 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -37.06M |
| Pretax Income | -34.10M |
| Net Income | -34.10M |
| EBITDA | -31.25M |
| EBIT | -33.96M |
| Earnings Per Share (EPS) | -$1.22 |
Balance Sheet
The company has $65.76 million in cash and $6.21 million in debt, giving a net cash position of $59.55 million or $2.38 per share.
| Cash & Cash Equivalents | 65.76M |
| Total Debt | 6.21M |
| Net Cash | 59.55M |
| Net Cash Per Share | $2.38 |
| Equity / Book Value | 64.90M |
| Book Value Per Share | 2.59 |
| Working Capital | 61.61M |
Cash Flow
In the last 12 months, operating cash flow was -$32.02 million and capital expenditures -$14,000, giving a free cash flow of -$32.04 million.
| Operating Cash Flow | -32.02M |
| Capital Expenditures | -14,000 |
| Free Cash Flow | -32.04M |
| FCF Per Share | -$1.15 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SNSE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.96% |
| Shareholder Yield | 8.96% |
| Earnings Yield | -138.38% |
| FCF Yield | -130.01% |
Analyst Forecast
The average price target for SNSE is $4.00, which is 308.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 308.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |